Vital Signs - Continued Opportunities in Diabetes Drug Delivery

Vital Signs - Continued Opportunities in Diabetes Drug Delivery

 

RELEASE DATE
26-Jan-2009
REGION
North America
Research Code: 9561-00-81-00-00
SKU: HC00560-NA-MR_04032
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00560-NA-MR_04032
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on January 26, 2009, provides a strategic overview of opportunities in drug delivery for the treatment of diabetes. Additionally, a company spotlight is provided for NanoBio Corporation, a company focused on the development and commercialization of topical and vaccine products utilizing its NanoStat technology platform. Reimbursement and regulatory news from the FDA is also provided for the week of January 12, 2009.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on January 26, 2009, provides a strategic overview of opportunities in drug delivery for the treatment of diabetes. Additionally, a company spotlight is provided for NanoBio Corporation, a company focused on the development and commercialization of topical and vaccine products utilizing its NanoStat technology platform. Reimbursement and regulatory news from the FDA is also provided for the week of January 12, 2009.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-81-00-00
Is Prebook No